Comparative in vitro study regarding the biocompatibility of titanium-base composites infiltrated with hydroxyapatite or silicatitanate

Journal of Biological Engineering

Volumn 8, Issue 1, 2014, Pages

  Brie, Ioana Carmen ^a,b   Soritau, Olga ^a   Dirzu, Noemi ^c   Berce, Cristian ^b   Vulpoi, Adriana ^d   Popa, Catalin ^c   Todea, Milica ^d   Simon, Simion ^d   Perde Schrepler, Maria ^a   Virag, Piroska ^a   Barbos, Otilia ^a   Chereches, Gabriela ^a   Berce, Petru ^c   Cernea, Valentin ^a,b  

^a THE ONCOLOGY INSTITUTE PROF DR ION CHIRICUTA   (Romania)

^b IULIU HATIEGANU UNIVERSITY OF MEDICINE AND PHARMACY   (Romania)

^c TECHNICAL UNIVERSITY OF CLUJ NAPOCA   (Romania)

^d BABE BOLYAI UNIVERSITY   (Romania)

Author keywords

Cell adhesion; Differentiation; Hydroxyapatite; Implants; Mineralization; Osteoblasts; Porous titanium; Silicatitanate

Indexed keywords

ALKALINE PHOSPHATASE; BONE MORPHOGENETIC PROTEIN 2; CALCIUM; COLLAGEN; HYDROXYAPATITE; INORGANIC SALT; NANOCOMPOSITE; OSTEOCALCIN; OSTEOPONTIN; SILICATITANATE; TITANIUM; TRANSFORMING GROWTH FACTOR BETA1; UNCLASSIFIED DRUG; BIOMATERIAL; SILICON DIOXIDE;

ARTICLE; BIOCOMPATIBILITY; BONE REGENERATION; CELL ADHESION; CELL DIFFERENTIATION; CELL PROLIFERATION; COLLAGEN SYNTHESIS; COMPARATIVE STUDY; EXTRACELLULAR MATRIX; HUMAN; HUMAN CELL CULTURE; IMMUNOCYTOCHEMISTRY; IN VITRO STUDY; OSTEOBLAST; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN SYNTHESIS; CELL CULTURE; CELL GROWTH; CONTROLLED STUDY; ENZYME ACTIVITY; ENZYME LINKED IMMUNOSORBENT ASSAY; HUMAN CELL; HUMAN TISSUE; IMPLANT; MICROSCOPY; MINERALIZATION; POROSITY; SCANNING ELECTON MICROSCOPY; STAINING;

EID: 84902702315     PISSN: None     EISSN: 17541611     Source Type: Journal    
DOI: 10.1186/1754-1611-8-14     Document Type: Article

References (78)

1. Baroli B. From natural bone grafts to tissue engineering therapeutics: brainstorming on pharmaceutical formulative requirements and challenges. J Pharm Sci 2009, 98(4):1317-1375.
2. Amini AR, Laurencin CT, Nukavarapu SP. Bone Tissue Engineering: Recent Advances and Challenges. Crit Rev Biomed Eng 2012, 40(5):363-408.
3. Sul YT, Johansson CB, Petronis S, Krozer A, Jeong Y, Wennerberg A, Albrektsson T. Characteristics of the surface oxides on turned and electrochemically oxidized pure titanium implants up to dielectric breakdown: the oxide thickness, micropore configurations, surface roughness, crystal structure and chemical composition. Biomaterials 2002, 23:491-501.
4. Park H, Temenoff JS, Mikos AG. Biodegradable orthopedic implants. Engineering of functional skeletal tissues 2007, 60. London: Spriinger-Verlagm, Bronner F, Farch-Carson MC, Mikos AG.
5. Ventre M, Causa F, Netti PA. Determinants of cell-material crosstalk at the interface: towards engineering of cell instructive materials. J R Soc Interface 2012, 9:2017-2032.
6. Nautiyal VP, Mittal A, Agarwal A, Pandey A. Tissue response to titanium implant using scanning electron microscope. Natl J Maxillofac Surg 2013, 4(1):7-12.
7. Ungersboeck A, Geret V, Pohler O, Schuetz M, Wuest W. Tissue reaction to bone plates made of pure titanium: a prospective, quantitative clinical study. J Mater Sci Mater Med 1995, 6:223-229.
8. Vijayaraghavan V, Sabane AV, Tejas K. Hypersensitivity to titanium: a less explored area of research. J Indian Prosthodont Soc 2012, 12(4):201-207.
9. Donesz-Sikorska A, Krzak-Roś J, Kochanowska IE, Be{ogonek}dziński R, Kaleta J. New specific metal-silica biocomposites for medical implants. Bioinspired, Biomimetic and Nanobiomaterials 08/2012; doi:10.1680/bbn.12.00018.
10. Nouri A, Hodgson PD, Wen C. Chapter 21- Biomimetic Porous Titanium Scaffolds for Orthopaedic and Dental Applications. Biomimetics, Learning from nature 2009, 415-450. In-Tech, Amitava M.
11. Marcu T, Todea M, Maines L, Leordean D, Berce P, Popa C. Metallurgical and mechanical characterisation of titanium based materials for endosseous applications obtained by selective laser melting. Powder Metall 2012, 55(4):309-314.
12. Kim HM. Ceramic bioactivity and related biomimetic strategy. Curr Opinion Solid State Mater Sci 2003, 7:289-299.
13. Jones JR. Review of bioactive glass: from Hench to hybrids. Acta Biomater 2013, 9(1):4457-4486.
14. Polo-Corrales L, Latorre-Esteves M, Ramirez-Vick JE. Scaffold design for bone regeneration. J Nanosci Nanotechnol 2014, 14(1):15-56.
15. Ning CQ, Zhou Y. On the microstructure of biocomposites sintered from Ti, HA and bioactive glass. Biomaterials 2004, 25:3379-3387.
16. Wu Z, He L, Chen Z. Fabrication and characterization of hydroxyapatite/Al2O3 biocomposite coating on titanium. Trans Nonferrous Met Soc China 2006, 16:259-266.
17. Wang CK, Lin JH, Ju CP, Ong HC, Chang RP. Structural characterization of pulsed laser-deposited hydroxyapatite film on titanium substrate. Biomaterials 1997, 18(20):1331-1338.
18. Prosecká E, Buzgo M, Rampichová M, Kocourek T, Kochová P, Vysloužilová L, Tvrdík D, Jelínek M, Lukáš D, Amler E. Thin-layer hydroxyapatite deposition on a nanofiber surface stimulates mesenchymal stem cell proliferation and their differentiation into osteoblasts. J Biomed Biotechnol 2012, 428503:10. doi:10.1155/2012/428503.
19. Roy M, Balla VK, Bandyopadhyay A, Bose S. Compositionally graded hydroxyapatite/ tricalcium phosphate coating on Ti by laser and induction plasma. Acta Biomater 2011, 7(2):866-873. doi:10.1016/j.actbio.2010.09.016.
20. Hannora AE, Mukasyan AS, Mansurov ZA. Nanocrystalline hydroxyapatite/si coating by mechanical alloying technique. Bioinorg Chem Appl 2012, 390104:14. doi:10.1155/2012/390104.
21. Kim HW, Kim HE, Knowles JC. Fluor-hydroxyapatite sol-gel coating on titanium substrate for hard tissue implants. Biomaterials 2004, 25(17):3351-3358.
22. Lin FH, Hsu YS, Lin SH, Sun JS. The effect of Ca/P concentration and temperature of simulated body fluid on the growth of hydroxyapatite coating on alkali-treated 316 L stainless steel. Biomaterials 2002, 23(19):4029-4038.
23. Eraković S, Janković A, Veljović D, Palcevskis E, Mitrić M, Stevanović T, Janaćković D, Mišković-Stanković V. Corrosion stability and bioactivity in simulated body fluid of silver/ hydroxyapatite and silver/ hydroxyapatite/ lignin coatings on titanium obtained by electrophoretic deposition. J Phys Chem B 2013, 117(6):1633-1643. doi:10.1021/jp305252a.
24. Mozafari M, Salahinejad E, Shabafrooz V, Yazdimamaghani M, Vashaee D, Tayebi L. Multilayer bioactive glass/zirconium titanate thin films in bone tissue engineering and regenerative dentistry. Int J Nanomedicine 2013, 8:1665-1672.
25. Saino E, Maliardi V, Quartarone E, Fassina L, Benedetti L, De Angelis MG, Mustarelli P, Facchini A, Visai L. In vitro enhancement of SAOS-2 cell calcified matrix deposition onto radio frequency magnetron sputtered bioglass-coated titanium scaffolds. Tissue Eng Part A 2010, 16(3):995-1008.
26. Leordean D, Dudescu C, Marcu T, Berce P, Bâlc N. Aspects related to the application of the selective laser melting technology to customized Ti-6Al-7Nb implants. J Rapid Prototyping in press.
27. Tomuleasa CI, Foris V, Soritau O, Pall E, Fisher-Fodor E, Lung-Illes V, Brie I, Virag P, Perde-Schrepler M, Postescu ID, Chereches G, Barbos O, Tatomir C. Effects of 60Co γ-rays on human osteoprogenitor cells. Rom J Morphol Embryol 2009, 50(3):349-355.
28. Søballe K. Hydroxyapatite ceramic coating for bone implant fixation. Mechanical and histological studies in dogs. Acta Orthop Scand Suppl 1993, 255:1-58.
29. Yim EK, Leong KW. Significance of synthetic nanostructures in dictating cellular response. Nanomedicine 2005, 1(1):10-21.
30. Wang G, Lu Z, Liu X, Zhou X, Ding C, Zreiqat H. Nanostructured glass-ceramic coatings for orthopaedic applications. J R Soc Interface 2011, 8(61):1192-1203. doi:10.1098/rsif.2010.0680.
31. Ponche A, Bigerelle M, Anselme K. Relative influence of surface topography and surface chemistry on cell response to bone implant materials. Part 1: Physico-chemical effects. Proc Inst Mech Eng H J Eng Med 2010, 224:1471.
32. Kitsugi T, Yamamuro T, Nakamura T, Oka M. Transmission electron microscopy observations at the interface of bone and four types of calcium phosphate ceramics with different calcium/phosphorus molar ratios. Biomaterials 1995, 16(14):1101-1107.
33. Chou YF, Huang W, Dunn JC, Miller TA, Wu BM. The effect of biomimetic apatite structure on osteoblast viability, proliferation, and gene expression. Biomaterials 2005, 26(3):285-295.
34. Goto T, Yoshinari M, Kobayashi S, Tanaka T. The initial attachment and subsequent behavior of osteoblastic cells and oral epithelial cells on titanium. Biomed Mater Eng 2004, 14(4):537-544.
35. Rampersad SN. Multiple applications of Alamar Blue as an indicator of metabolic function and cellular health in cell viability bioassays. Sensors (Basel) 2012, 12(9):12347-12360. doi:10.3390/s120912347.
36. Geys J, Nemery B, Hoet PH. Assay conditions can influence the outcome of cytotoxicity tests of nanomaterials: better assay characterization is needed to compare studies. Toxicol In Vitro 2010, 24(2):620-629. doi:10.1016/j.tiv.2009.10.007.
37. Zeller KS, Riaz A, Sarve H, Li J, Tengholm A, Johansson S. The role of mechanical force and ROS in integrin-dependent signals. PLoS ONE 8(5):e64897. doi:10.1371/journal.pone.0064897.
38. Harmey D, Hessle L, Narisawa S, Johnson KA, Terkeltaub R, Millán JL. Concerted regulation of inorganic pyrophosphate and osteopontin by akp2, enpp1, and ank: an integrated model of the pathogenesis of mineralization disorders. Am J Pathol 2004, 164(4):1199-1209.
39. Addison WN, Azari F, Sørensen ES, Kaartinen MT, McKee MD. Pyrophosphate inhibits mineralization of osteoblast cultures by binding to mineral, up-regulating osteopontin, and inhibiting alkaline phosphatase activity. J Biol Chem 2007, 282(21):15872-15883.
40. Khan MR, Donos N, Salih V, Brett PM. The enhanced modulation of key bone matrix components by modified Titanium implant surfaces. Bone 2012, 50(1):1-8. doi:10.1016/j.bone.2011.07.040.
41. Albrektsson T, Johansson C. Osteoinduction, osteoconduction and osseointegration. Eur Spine J 2001, 10(Suppl 2):S96-S101.
42. Barradas AM, Yuan H, Van Blitterswijk CA, Habibovic P. Osteoinductive biomaterials: current knowledge of properties, experimental models and biological mechanisms. Eur Cell Mater 2011, 21:407-429.
43. Anselme K, Ponche A, Bigerelle M. Relative influence of surface topography and surface chemistry on cell response to bone implant materials. Part 2: biological aspects. Proc Inst Mech Eng H 2010, 224(12):1487-1507.
44. Lutolf MP, Hubbell JA. Synthetic biomaterials as instructive extracellular microenvironments for morphogenesis in tissue engineering. Nat Biotechnol 2005, 23:47-55.
45. Waselau M, Patrikoski M, Juntunen M, Kujala K, Kääriäinen M, Kuokkanen H, Sándor GK, Vapaavuori O, Suuronen R, Mannerström B, Von Rechenberg B, Miettinen S. Effects of bioactive glass S53P4 or beta-tricalcium phosphate and bone morphogenetic protein-2 and bone morphogenetic protein-7 on osteogenic differentiation of human adipose stem cells. J Tissue Eng 2012, 3(1):2041731412467789. doi:10.1177/2041731412467789.
46. Drnovšek N, Novak S, Dragin U, Čeh M, Gorenšek M, Gradišar M. Bioactive glass enhances bone ingrowth into the porous titanium coating on orthopaedic implants. Int Orthop 2012, 36(8):1739-1745. doi:10.1007/s00264-012-1520-y.
47. Ponta O, Vanea E, Cheniti A, Berce P, Simon S. Structural and surface characterization of nanostructured spray dried titanosilicate microspheres. Mater Chem Phys 2012, 135:863-869.
48. Rahaman MN, Day DE, Bal BS, Fu Q, Jung SB, Bonewald LF, Tomsia AP. Bioactive glass in tissue engineering. Acta Biomater 2011, 7(6):2355-2373. doi:10.1016/j.actbio.2011.03.016.
49. Mahony O, Jones JR. Porous bioactive nanostructured scaffolds for bone regeneration: a sol-gel solution. Nanomedicine (Lond) 2008, 3(2):233-245. doi:10.2217/17435889.3.2.233.
50. Pamula E, Kokoszka J, Cholewa-Kowalska K, Laczka M, Kantor L, Niedzwiedzki L, Reilly GC, Filipowska J, Madej W, Kolodziejczyk M, Tylko G, Osyczka AM. Degradation, bioactivity, and osteogenic potential of composites made of PLGA and two different sol-gel bioactive glasses. Ann Biomed Eng 2011, 39(8):2114-2129. doi:10.1007/s10439-011-0307-4.
51. Jones JR, Lin S, Yue S, Lee PD, Hanna JV, Smith ME, Newport RJ. Bioactive glass scaffolds for bone regeneration and their hierarchical characterisation. Proc Inst Mech Eng H 2010, 224(12):1373-1387.
52. Jugdaohsingh R. Silicon and bone health. J Nutr Health Aging 2007, 11(2):99-110.
53. McKee MD, Nanci A. Osteopontin at mineralized tissue interfaces in bone, teeth, and osseointegrated implants: ultrastructural distribution and implications for mineralized tissue formation, turnover, and repair. Microsc Res Tech 1996, 33(2):141-164.
54. Gericke A, Qin C, Spevak L, Fujimoto Y, Butler WT, Sørensen ES, Boskey AL. Importance of phosphorylation for osteopontin regulation of biomineralization. Calcif Tissue Int 2005, 77(1):45-54.
55. Vandrovcová M, Bačáková L. Adhesion, growth and differentiation of osteoblasts on surface-modified materials developed for bone implants. Physiol Res 2011, 60(3):403-417.
56. Roffers-Agarwal J, Xanthos JB, Miller JR. Regulation of actin cytoskeleton architecture by Eps8 and Abi1. BMC Cell Biol 2005, 6:36.
57. Orza A, Soritau O, Olenic L, Diudea M, Florea A, Rus Ciuca D, Mihu C, Casciano D, Biris AS. Electrically conductive gold-coated collagen nanofibers for placental-derived mesenchymal stem cells enhanced differentiation and proliferation. ACS Nano 2011, 5(6):4490-4503. doi:10.1021/nn1035312.
58. Galli C, Piemontese M, Lumetti S, Ravanetti F, Macaluso GM, Passeri G. Actin cytoskeleton controls activation of Wnt/β-catenin signaling in mesenchymal cells on implant surfaces with different topographies. Acta Biomater 2012, 8(8):2963-2968. doi:10.1016/j.actbio.2012.04.043.
59. Kazanecki CC, Uzwiak DJ, Denhardt DT. Control of osteopontin signaling and function by post-translational phosphorylation and protein folding. J Cell Biochem 2007, 102(4):912-924.
60. Hunter LW, Shiekh FA, Pisimisis GT, Kim SH, Edeh SN, Miller VM, Lieske JC. Key role of alkaline phosphatase in the development of human-derived nanoparticles in vitro. Acta Biomater 2011, 7(3):1339-1345. doi:10.1016/j.actbio.2010.10.027.
61. Yamada M, Ueno T, Tsukimura N, Ikeda T, Nakagawa K, Hori N, Suzuki T, Ogawa T. Bone integration capability of nanopolymorphic crystalline hydroxyapatite coated on titanium implants. Int J Nanomedicine 2012, 7:859-873. doi:10.2147/IJN.S28082.
62. Ochiai H, Okada S, Saito A, Hoshi K, Yamashita H, Takato T, Azuma T. Inhibition of insulin-like growth factor-1 (IGF-1) expression by prolonged transforming growth factor-β1 (TGF-β1) administration suppresses osteoblast differentiation. J Biol Chem 2012, 287(27):22654-22661. doi:10.1074/jbc.M111.279091.
63. Kanaan RA, Kanaan LA. Transforming growth factor beta1, bone connection. Med Sci Monit 2006, 12(8):RA164-RA169.
64. Tirkkonen L, Haimi S, Huttunen S, Wolff J, Pirhonen E, Sándor GK, Miettinen S. Osteogenic medium is superior to growth factors in differentiation of human adipose stem cells towards bone-forming cells in 3D culture. Eur Cell Mater 2013, 25:144-158.
65. Cruz AC, Silva ML, Caon T, Simões CM. Addition of bone morphogenetic protein type 2 to ascorbate and β-glycerophosphate supplementation did not enhance osteogenic differentiation of human adipose-derived stem cells. J Appl Oral Sci 2012, 20(6):628-635.
66. Zuk P, Chou YF, Mussano F, Benhaim P, Wu BM. Adipose-derived stem cells and BMP2: part 2. BMP2 may not influence the osteogenic fate of human adipose-derived stem cells. Connect Tissue Res 2011, 52(2):119-132. doi:10.3109/03008207.2010.484515.
67. Khanna-Jain R, Agata H, Vuorinen A, Sándor GK, Suuronen R, Miettinen S. Addition of BMP-2 or BMP-6 to dexamethasone, ascorbic acid, and β-glycerophosphate may not enhance osteogenic differentiation of human periodontal ligament cells. Growth Factors 2010, 28(6):437-446. doi:10.3109/08977194.2010.495719.
68. Raggatt LJ, Partridge NC. Cellular and Molecular Mechanisms of Bone Remodeling. J Biol Chem 2010, 285(33):25103-25108. doi:10.1074/jbc.R109.041087.
69. Jang WG, Kim EJ, Kim DK, Ryoo HM, Lee KB, Kim SH, Choi HS, Koh JT. BMP2 protein regulates osteocalcin expression via Runx2-mediated Atf6 gene transcription. J Biol Chem 2012, 287(2):905-915. doi:10.1074/jbc.M111.253187.
70. Pilia M, Guda T, Shiels SM, Appleford MR. Influence of substrate curvature on osteoblast orientation and extracellular matrix deposition. J Biol Eng 2013, 7(1):23.
71. Roach HI. Why does bone matrix contain non-collagenous proteins? The possible roles of osteocalcin, osteonectin, osteopontin and bone sialoprotein in bone mineralisation and resorption. Cell Biol Int 1994, 18(6):617-628.
72. Silver IA, Deas J, Erecińska M. Interactions of bioactive glasses with osteoblasts in vitro: effects of 45S5 Bioglass, and 58S and 77S bioactive glasses on metabolism, intracellular ion concentrations and cell viability. Biomaterials 2001, 22(2):175-185.
73. Arumugam MQ, Ireland DC, Brooks RA, Rushton N, Bonfield W. The Effect Orthosilicic Acid on Collagen Type I, Alkaline Phosphatase and Osteocalcin mRNA Expression in Human Bone-Derived Osteoblasts. In Vitro Key Engineering Materials 2006, 309-311:125. doi:10.4028/www.scientific.net/KEM.254-256.869.
74. Bosetti M, Zanardi L, Hench L, Cannas M. Type I collagen production by osteoblast-like cells cultured in contact with different bioactive glasses. J Biomed Mater Res A 2003, 64(1):189-195.
75. Meury T, Akhouayri O, Jafarov T, Mandic V, St-Arnaud R. Nuclear alpha NAC influences bone matrix mineralization and osteoblast maturation in vivo. Mol Cell Biol 2010, 30(1):43-53. doi:10.1128/MCB.00378-09.
76. Boskey AL, Gadaleta S, Gundberg C, Doty SB, Ducy P, Karsenty G. Fourier transform infrared microspectroscopic analysis of bones of osteocalcin-deficient mice provides insight into the function of osteocalcin. Bone 1998, 23:187-196.
77. Gómez-Morales J, Iafisco M, Delgado-López JM, Sarda S, Drouet C. Progress on the preparation of nanocrystalline apatites and surface characterization: Overview of fundamental and applied aspects. Prog Cryst Growth Charact Mater 2013, 59:1-46.
78. Hayashi K, Fotovati A, Ali SA, Oda K, Oida H, Naito M. Prostaglandin EP4 receptor agonist augments fixation of hydroxyapatite-coated implants in a rat model of osteoporosis. J Bone Joint Surg (Br) 2005, 87(8):1150-1156.